0001181431-13-007792.txt : 20130207 0001181431-13-007792.hdr.sgml : 20130207 20130207192846 ACCESSION NUMBER: 0001181431-13-007792 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130205 FILED AS OF DATE: 20130207 DATE AS OF CHANGE: 20130207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schwabe Stefan K.F. CENTRAL INDEX KEY: 0001557657 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35518 FILM NUMBER: 13584294 MAIL ADDRESS: STREET 1: C/O SUPERNUS PHARMACEUTICALS, INC. STREET 2: 1550 EAST GUDE DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001356576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 1550 E GUDE DR CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-838-2500 MAIL ADDRESS: STREET 1: 1550 E GUDE DR CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 rrd368996.xml X0306 4 2013-02-05 0 0001356576 SUPERNUS PHARMACEUTICALS INC SUPN 0001557657 Schwabe Stefan K.F. C/O SUPERNUS PHARMACEUTICALS, INC. 1550 EAST GUDE DRIVE ROCKVILLE MD 20850 0 1 0 0 Executive Vice President R&D Common Stock 2051 D Employee Stock Option (Right to Buy) 7.90 2013-02-05 4 A 0 20000 0 A 2023-02-05 Common Stock 20000 20000 D The option vests in four equal annual installments beginning on February 5, 2014. Includes 2,051 shares acquired under the Supernus stock purchase plan on December 31, 2012. /s/ Gregory S. Patrick, as attorney-in-fact 2013-02-07